IOVA
Iovance (IOVA) Reports Wider Q4 Loss of $0.18/Share as Revenue Surges 28.7% to $86.8M
Iovance posts wider Q4 loss of $0.18/share but revenue surges 28.7% sequentially to $86.8M, driving 12% stock rally despite profitability…
Iovance Biotherapeutics, inc (IOVA) Q2 2022 Earnings Call
Iovance Biotherapeutics, inc (NASDAQ: IOVA) Q2 2022 Earnings Conference
Iovance Biotherapeutics, inc (IOVA) Q1 2022 Earnings Conference Call
Iovance Biotherapeutics, inc (NASDAQ: IOVA) Q1 2022 Earnings Conference
Iovance Biotherapeutics, inc (IOVA) Q4 2021 earnings call
Iovance Biotherapeutics, inc (NASDAQ: IOVA) Q4 2021 Earnings Conference
Iovance Biotherapeutics, inc (IOVA) 3Q21 Earnings Call
Iovance Biotherapeutics, inc (NASDAQ: IOVA) Q3 2021 Earnings Conference
Iovance Biotherapeutics, inc (IOVA) Q2 2021 Earnings Call
Iovance Biotherapeutics, inc (NASDAQ: IOVA) Q2 2021 Earnings Conference
Iovance Biotherapeutics, inc (IOVA) ovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021
Iovance Biotherapeutics, inc (NASDAQ: IOVA) Q4 2020 Earnings Conference